HIGHLIGHTS
- who: Mohammad Sadeghi from the Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran have published the article: The prognostic and therapeutic potential of HO-1 in leukemia and MDS, in the Journal: (JOURNAL)
- what: In this article, the role of HO-1 in MDS and leukemia is reviewed and its prognostic role as well as its targeting effect in different leukemias and MDS is determined. The findings of the research suggest that HO-1 can be used as a novel target to help eliminate Minimal Residual Disease (MRD) in AML patients since it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.